scispace - formally typeset
M

María Ibáñez-Vea

Researcher at University of Southern Denmark

Publications -  15
Citations -  748

María Ibáñez-Vea is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Cancer cell & Tumor microenvironment. The author has an hindex of 10, co-authored 15 publications receiving 525 citations.

Papers
More filters
Journal ArticleDOI

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity.

TL;DR: PDL1 cell-intrinsic signaling protects cancer cells from interferon (IFN) cytotoxicity and accelerates tumor progression and reveals a mode of action of PDL1 in cancer cells as a first line of defense against IFN cytot toxicity.
Journal ArticleDOI

PD1 signal transduction pathways in T cells

TL;DR: The current knowledge on PD1-dependent intracellular signaling pathways, and the consequences of disrupting PD1 signal transduction are reviewed.
Journal ArticleDOI

Quantitative proteomics analysis of platelet-derived microparticles reveals distinct protein signatures when stimulated by different physiological agonists.

TL;DR: The protein profile of PMPs obtained by performing four different activation protocols using mass spectrometry-based quantitative proteomics is investigated to suggest a biological link between agonist strength and proteins associated to platelet mediated processes such as activation and degranulation.
Journal ArticleDOI

Simultaneous Enrichment of Cysteine-containing Peptides and Phosphopeptides Using a Cysteine-specific Phosphonate Adaptable Tag (CysPAT) in Combination with titanium dioxide (TiO2) Chromatography

TL;DR: The CysPAT strategy is a straight forward, easy and promising method for studying redox proteomics and the simultaneous enrichment strategy offers an excellent solution for characterization of cross-talk between phosphorylation and redox induced reversible cysteine modifications.
Journal ArticleDOI

Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer

TL;DR: The overexpression of ST3GAL4 interferes with the overall glycophenotype of cancer cells affecting a multitude of key proteins involved in malignancy, and points to an integrative tumor glycomic/proteomic-profiling for gastric cancer patients' stratification.